Oramed Pharmaceuticals Inc. (ORMP) Financials

ORMP Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 97.6 million 12.0 million
Sept. 30, 2025 220.5 million 18.2 million
June 30, 2025 161.7 million 8.1 million
March 31, 2025 147.5 million 7.6 million

ORMP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -4.1 million 396000
Sept. 30, 2025 -2.0 million 719000
June 30, 2025 -3.6 million 800000
March 31, 2025 -3.5 million 2.2 million

ORMP Net Income

No data available :(

ORMP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 51.4 million 540000 825000
Sept. 30, 2025 134.7 million - 860000
June 30, 2025 97.9 million - 912000
March 31, 2025 130.6 million - 301000

ORMP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 42.4 million
Sept. 30, 2025 42.8 million
June 30, 2025 42.6 million
March 31, 2025 41.2 million

ORMP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 4000 2.0 million 3.7 million -
Sept. 30, 2025 289 1.2 million 1.3 million -
June 30, 2025 4028 1.0 million 1.5 million -
March 31, 2025 2999 2.2 million 2.3 million -

ORMP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 - -61000
Sept. 30, 2025 - 31000
June 30, 2025 - 30000
March 31, 2025 2.0 million 2.0 million

ORMP

Price: $3.77

52 week price:
1.98
5.01

Dividend Yield: 6.85%

Earnings Per Share: 1.50 USD

P/E Ratio: 2.26

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.6 million

Ebitda: -2.5 million

Market Capitalization: 149.4 million

Years Paying Dividends: 1

Links: